Welcure Drugs Statements
52
Welcure Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
100
—
0
—
0
—
0
0.27
0
1.236
0
-1.236
0
—
0
0.024
0
-1.282
0
—
0
-1.282
0
-0.072
89.756
—
100
—
0
—
0
—
0
0.072
0
0.718
0
-0.718
0
—
0
0.09
0
-0.628
0
—
0
-0.628
0
-0.046
13.476
0.825
100
—
0
—
0
—
0
0.074
4.4
0.216
18.9
0.609
81.1
—
0
0.002
0
0.611
81.1
—
0
0.611
81.1
0.036
13.412
0.225
100
—
0
—
0
—
0
0.057
0
0.6
0
-0.375
0
—
0
—
0
-0.375
0
—
0
-0.375
0
-0.03
12.75
0.52
100
—
0
—
0
—
0
0.042
4
0.157
22.7
0.363
77.3
—
0
-0.004
-0.8
0.359
76.5
—
0
0.359
76.5
0.03
12.119
0.813
100
—
0
0.813
100
—
0
0.042
6.9
0.627
57.4
0.186
42.6
—
0
0.006
2
0.192
44.6
—
0
0.192
44.6
0.016
12.119
0.1
100
—
0
—
0
—
0
0.042
21
0.277
168.8
-0.177
-68.8
—
0
0.004
3.5
-0.173
-65.3
—
0
-0.173
-65.3
-0.014
12.119
0.725
100
—
0
0.725
100
—
0
0.042
7
0.646
62
0.079
38
—
0
—
0
0.079
38
—
0
0.079
38
0.007
12.119